IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice - PubMed

Affiliations

• PMID: 9759845

Comparative Study

IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice

E Bettelli et al. J Immunol. 1998.

Abstract

Experimental autoimmune encephalomyelitis (EAE) and other organ-specific autoimmune diseases are induced by autoantigen-specific Th1 cells. In contrast, transfer of autoantigen-reactive Th2 cells that produce IL-4 and IL-10 can prevent and/or reverse EAE. The relative roles of these two Th2 cytokines in the regulation of EAE has not been evaluated. Utilizing IL-4 and IL-10 knockout mice deficient for these cytokines and IL-10 and IL-4 transgenic mice overexpressing these cytokines, we demonstrate that IL-10-deficient mice (IL-10(-/-)) are more susceptible and develop a more severe EAE when compared with IL-4-deficient mice (IL-4(-/-)) or wild-type mice. T cells from IL-10(-/-) mice exhibit a stronger Ag-specific proliferation, produce more proinflammatory cytokines (IFN-gamma and TNF-alpha) when stimulated with an encephalitogenic peptide, and induce very severe EAE upon transfer into wild-type mice. In contrast, while IL-4 transgenic mice develop similar disease compared with their nontransgenic littermates, mice transgenic for IL-10 are completely resistant to the development of EAE. Taken together, our data suggest that IL-10 plays a more critical role in the regulation of EAE by regulating autopathogenic Th1 responses.

Similar articles

• IL-10 mediates resistance to adoptive transfer experimental autoimmune encephalomyelitis in MyD88(-/-) mice.

  Cohen SJ, Cohen IR, Nussbaum G. Cohen SJ, et al. J Immunol. 2010 Jan 1;184(1):212-21. doi: 10.4049/jimmunol.0900296. Epub 2009 Nov 30. J Immunol. 2010. PMID: 19949074

• Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.

  Samoilova EB, Horton JL, Chen Y. Samoilova EB, et al. Cell Immunol. 1998 Sep 15;188(2):118-24. doi: 10.1006/cimm.1998.1365. Cell Immunol. 1998. PMID: 9756642

• The roles of Galectin-3 in autoimmunity and tumor progression.

  Radosavljevic G, Volarevic V, Jovanovic I, Milovanovic M, Pejnovic N, Arsenijevic N, Hsu DK, Lukic ML. Radosavljevic G, et al. Immunol Res. 2012 Apr;52(1-2):100-10. doi: 10.1007/s12026-012-8286-6. Immunol Res. 2012. PMID: 22418727 Review.

Cited by

• Interleukin-10 plays a crucial role in suppression of experimental autoimmune encephalomyelitis by Bowman-Birk inhibitor.

  Dai H, Ciric B, Zhang GX, Rostami A. Dai H, et al. J Neuroimmunol. 2012 Apr;245(1-2):1-7. doi: 10.1016/j.jneuroim.2012.01.005. Epub 2012 Feb 25. J Neuroimmunol. 2012. PMID: 22365083 Free PMC article.

• T-cell cytokines in injury-induced neural damage and repair.

  Schroeter M, Jander S. Schroeter M, et al. Neuromolecular Med. 2005;7(3):183-95. doi: 10.1385/NMM:7:3:183. Neuromolecular Med. 2005. PMID: 16247179 Review.

• Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration.

  Chitnis T, Imitola J, Wang Y, Elyaman W, Chawla P, Sharuk M, Raddassi K, Bronson RT, Khoury SJ. Chitnis T, et al. Am J Pathol. 2007 May;170(5):1695-712. doi: 10.2353/ajpath.2007.060677. Am J Pathol. 2007. PMID: 17456775 Free PMC article.

• Heme oxygenase-1 and carbon monoxide suppress autoimmune neuroinflammation.

  Chora AA, Fontoura P, Cunha A, Pais TF, Cardoso S, Ho PP, Lee LY, Sobel RA, Steinman L, Soares MP. Chora AA, et al. J Clin Invest. 2007 Feb;117(2):438-47. doi: 10.1172/JCI28844. Epub 2007 Jan 25. J Clin Invest. 2007. PMID: 17256058 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)